Bal Pharma commences commercial production of intermediates, API at Udaipur unit

03 Dec 2018 Evaluate

Bal Pharma has commenced commercial production of intermediates and Active Pharma Ingredients (API) at its bulk drugs manufacturing unit in Udaipur. The APL products which of scheduled to be manufactured at this Unit were developed by the company’s R&D facility at Bangalore and due to capacity constraints at Bangalore facility it could not become commercially viable till now.

This unit is expected to ease the capacity concerns of API's and intermediates and will cater to the North are Northeastern markets of the country and also overseas markets.

Bal Pharma is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.

Bal Pharma Share Price

101.98 -1.09 (-1.06%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...